TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Acotec Scientific Holdings Limited ( (HK:6669) ).
Acotec Scientific Holdings Limited announced that it has received approval from the PRC National Medical Products Administration for its Coronary Over-the-Wire Balloon Dilatation Catheter Jingyi. This product is designed to improve myocardial perfusion by addressing complex coronary artery lesions, and the company plans to market it in the PRC. The approval marks a significant step in Acotec’s product development, potentially enhancing its market position in the cardiovascular medical device sector.
The most recent analyst rating on (HK:6669) stock is a Hold with a HK$14.50 price target. To see the full list of analyst forecasts on Acotec Scientific Holdings Limited stock, see the HK:6669 Stock Forecast page.
More about Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a company incorporated in the Cayman Islands, focusing on the medical device industry. The company specializes in developing innovative medical products, particularly in the field of cardiovascular devices.
Average Trading Volume: 710,298
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.36B
For detailed information about 6669 stock, go to TipRanks’ Stock Analysis page.